Effect of the MIROKI Companion Robot on Anxiety in Pediatric Radiotherapy

Starting soon

Conditions studied: Pediatric Oncology, Radiotherapy, Parent

In brief

Pediatric radiotherapy is an anxiety-provoking situation that can, on one hand, impair the child's cooperation and require sedation, and on the other hand,burden the care pathway by generating significant anxiety in both the child and their parents. Companion robots represent an innovative avenue for patient support, but they have never been evaluated in the context of radiotherapy. This study examines the effect of MIROKI, the first social robot capable of communication through a Large Multimodal Model (LMM), on children's state anxiety during radiotherapy. An experimental single-case design (SCED) will compare phases with and without the robot (withdrawal/reversal), both in the waiting room and in the irradiation bunker. The primary outcome variable is anxiety, assessed in several ways: through questionnaires at the beginning and end of treatment; through an objective measure of cardiac activity (heart rate in bpm) during the radiotherapy session, with or without the MIROKI robot; and through an observational grid assessing the child's behavior. The intensive repeated measure (bpm) constitutes the preferred variable in this SCED design, while behavioral observation and anxiety questionnaires will support interpretation. The results could pave the way for reducing sedation and improving the overall care pathway in pediatric radiotherapy.

Key facts

Study ID

NCT07645950

Run by

Institut du Cancer de Montpellier - Val d'Aurelle

People needed

6

Starts

2026-07-01

Expected to finish

2027-07-01

Last updated by the study team

2026-06-12

Who can join

Age: 4 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Children aged 4 to 18 years, distributed across the following age groups: 4-7 years, 8-12 years, and 13-18 years.
• Child with an indication for radiotherapy treatment at ICM.
• Child who speaks French.
• Child accompanied by a parent or legal guardian who agrees to participate in the study and provide consent.
• Child covered by the French national health insurance system.

You may not qualify if…

• Child with a diagnosed neurodevelopmental disorder as a comorbidity. 7. Child with postoperative cognitive sequelae that make interaction during care difficult (e.g., language impairment). 8. Total body irradiation. 9. Child under legal protection, unable to express assent, or presenting major difficulties in understanding the study information. Parent Inclusion Criteria
• Parent of a child enrolled in the study.
• Able to speak French.
• Willing to participate in the study. Parent Exclusion Criteria
• Parents or legal representatives under legal protection, or presenting an inability to consent or to understand the study information, making it impossible to provide free and informed consent for the minor's participation.

Where it is running

• Julien Welmant — Montpellier, Herault, France

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.